Technion Research and Development Foundation

CAPS Medical is a medical device company focused on the development and commercialization of cancer treatment using Cold Atmospheric Plasma. The company aims to deliver minimally invasive selective cancer treatment and enable fine-tuning of the delivered energy dose. CAPS Medical was founded following extensive scientific research as a collaboration between the Technion’s Plasma Lab and Rambam Medical Center’s Cancer Lab, united in the fight against cancer. The company is addressing an unmet need in the multi-billion dollar oncology therapeutics market. CAPS Medical was founded by Ilan Uchitel in 2018.

AmplioSpeech maximizes student outcomes and empowers SLPs, by delivering Digital Speech-Language Therapy to school districts and their SLPs, students and their families, special education departments and administrators. Powered by an award-winning artificial intelligence technology, AmplioSpeech equips school districts with an exclusive speech-language therapy operating system that powers speech-language therapy in the 21st century. AmplioSpeech accelerates student clinical and academic progress using proven, individualized digital programs, reduces SLPs indirect workload, all while ensuring efficient and consistent IEP compliance both onsite and online. School districts empower their school-based SLPs using the AmplioSpeech system or deploy AmplioSpeech SLPs to complement. Special education administrators leverage on the most advanced platform that adapts to their school’s needs. AmplioSpeech provides them exclusive access to monitoring and oversight on compliance and progress, and a 360° view of where things stand at any given time.

Avraham Pharmaceuticals Ltd. is a privately held pharmaceutical company based in Yavne, Israel, established in 2010. The company focuses on developing innovative products aimed at the treatment and prevention of neurodegenerative disorders. Its lead product candidate, Ladostigil, is designed to address mild cognitive impairment and employs multifunctional compounds that offer neuroprotective benefits. These mechanisms include the reduction of oxidative stress and microglial activation, as well as the inhibition of pro-inflammatory cytokines. Avraham Pharmaceuticals has raised $9 million to support clinical trials, including a European Phase II proof-of-concept efficacy trial targeting Alzheimer's disease.

Correlsense helps businesses achieve IT reliability by detecting degradations and outages caused by poorly performing applications. The company’s award-winning flagship product, SharePath, tracks every transaction through each hop in the data center, providing unprecedented visibility into the infrastructure. Easy to deploy and maintain, SharePath is used by businesses of all sizes to optimize the end-user experience, to minimize the risks associated with new service roll-outs and data center migration, to issue chargebacks for IT resources consumed, and to improve the capacity planning process. The company offers an Express edition of SharePath to measure the end-user experience of cloud-based and on-premise applications. This free enterprise-class software can be downloaded at http://www.real-user-monitoring.com. Correlsense was founded in 2005 and is privately held.

DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era. -The first really affordable Computer-to-Plate solution for quality in-house plate making -Ideal for narrow web applications printers -A great motivation to replace the traditional low quality film solution -The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track

DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era. -The first really affordable Computer-to-Plate solution for quality in-house plate making -Ideal for narrow web applications printers -A great motivation to replace the traditional low quality film solution -The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track

Corindus Vascular Robotics, Inc. specializes in the design, manufacture, and commercialization of robotic-assisted systems for interventional vascular procedures. Based in Waltham, Massachusetts, the company offers the CorPath system, which allows physicians to perform catheterization procedures from a radiation-shielded control console, enhancing precision and safety in coronary and peripheral interventions. The CorPath GRX system further enables the robotic-assisted control of guide catheters, guidewires, and balloon/stent devices. Corindus serves various markets, including vascular, coronary, neurointerventional, and structural heart fields, selling its products through a combination of direct sales and partnerships. Founded in 2002, Corindus is a subsidiary of Siemens Medical Solutions USA, Inc. as of late 2019.